What happens when you take carbamazepine with biotin?
Carbamazepine (Tegretol, Carbatrol, Equetro, Epitol) is a first-line anticonvulsant for focal seizures and trigeminal neuralgia. Although less famous than the carbamazepine-vitamin D interaction, the drug also reliably reduces biotin status, and this has been recognized in the literature for decades.
The mechanism is layered. First, carbamazepine inhibits the sodium-dependent multivitamin transporter (SMVT) in the intestinal brush border, which is the primary route for biotin uptake from the diet. Second, it appears to reduce renal tubular reabsorption of biotin, meaning more is lost in the urine. Third, carbamazepine — like other enzyme-inducing anticonvulsants — accelerates biotin catabolism to inactive metabolites (such as bisnorbiotin and biotin sulfoxide). Animal data show that dietary carbamazepine decreases hepatic pyruvate carboxylase activity and protein biotinylation, consistent with functional biotin insufficiency at the cellular level.
The result is that long-term carbamazepine users — both children and adults — tend to show subnormal plasma biotin and elevated urinary 3-hydroxyisovaleric acid (a biomarker of biotin status). Frank biotin deficiency is uncommon, but biotin insufficiency appears to be widespread among chronic anticonvulsant users, with some studies estimating that the majority of long-term users are affected to some degree.
Why is this important?
Biotin (vitamin B7) is a coenzyme for five carboxylases involved in fatty-acid synthesis, gluconeogenesis, amino-acid metabolism, and propionate metabolism. Clinical signs of biotin deficiency include hair thinning or loss (one of the more visible signs in carbamazepine and valproate users), brittle nails, seborrheic dermatitis, conjunctivitis, depression, paresthesias, and — in severe cases in children — neurologic symptoms and seizures.
There is a particularly important wrinkle in pediatric epilepsy: biotinidase deficiency is itself a treatable cause of infantile seizures. If an anticonvulsant masks part of the picture while also reducing biotin further, the underlying problem can go undetected. Newborn screening now covers biotinidase deficiency in most US states, but clinicians caring for children with epilepsy on long-term carbamazepine still keep biotin status on the differential when treatment-resistant symptoms appear.
The Linus Pauling Institute's Micronutrient Information Center specifically lists carbamazepine (along with primidone, phenytoin, and phenobarbital) as agents that can reduce blood biotin concentrations.
What should you do?
Talk to your prescriber if you have been on carbamazepine long-term, especially if you are noticing hair thinning, skin changes, or unexplained fatigue. A standard B-complex multivitamin containing 30 to 300 mcg of biotin (the adequate intake for adults is 30 mcg per day) is generally enough to offset anticonvulsant-related losses and is well within the safe-intake range.
Avoid high-dose biotin in the 5 to 10 mg range unless your prescriber specifically recommends it. The reason is not toxicity — biotin has no established upper limit — but rather laboratory interference. High-dose biotin can produce falsely low or falsely high results on biotin-streptavidin-based immunoassays, including some thyroid panels, troponin tests, parathyroid hormone, vitamin D, and reproductive hormones. The FDA has issued a specific safety alert on this. If you are taking high-dose biotin, stop it at least 24 to 72 hours before lab draws.
Track biotin intake and any skin, hair, or nail symptoms in Pilora alongside your carbamazepine schedule. If you are caring for a child on long-term carbamazepine, ask the pediatric neurologist about routine biotin status assessment.
Which specific products are affected?
On the drug side, this includes all carbamazepine products (Tegretol, Tegretol XR, Carbatrol, Equetro, Epitol, generics) and the closely related oxcarbazepine (Trileptal) and eslicarbazepine (Aptiom). The same biotin-depleting effect has been documented for phenobarbital, primidone, and phenytoin. Valproate also reduces biotin, possibly through a different mechanism involving biotinidase inhibition.
On the supplement side, biotin appears as standalone tablets (typically 1, 5, or 10 mg per tablet), in B-complex products, in multivitamins (usually around 30 to 50 mcg), and in many "hair, skin, and nails" formulas (often 2.5 to 10 mg). For carbamazepine-related insufficiency, low-dose products in a multivitamin or B-complex are appropriate; the very high-dose hair-and-nails products are usually unnecessary and create the lab-interference issue noted above.
The bottom line
Carbamazepine reduces biotin absorption, increases urinary loss, and accelerates biotin catabolism, leading to subnormal biotin status in many long-term users. A multivitamin or B-complex containing 30 to 300 mcg of biotin is a reasonable hedge, especially in children, patients with hair or skin changes, or those on polytherapy. Avoid high-dose (5 mg+) biotin around lab draws because of immunoassay interference.